Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity

v3.22.2.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Beginning balance at Jan. 31, 2021 $ 31,541 $ 378 $ 246,446 $ (227) $ (73) $ (214,983)
Beginning balance, Shares at Jan. 31, 2021   37,811,224        
Issuance of common stock pursuant to vesting of restricted stock units   $ 10 (10)      
Issuance of common stock pursuant to vesting of restricted stock units, shares   981,927        
Issuance of common stock pursuant to exercise of stock options 137 $ 1 136      
Issuance of common stock pursuant to exercise of stock options, shares   95,538        
Issuance of common stock, net of issuance costs 17,462 $ 103 17,359      
Issuance of common stock, net of issuance costs, shares   10,323,484        
Stock-based compensation expense 1,315   1,315      
Unrealized gains on marketable securities 1       1  
Foreign currency translation adjustments (649)       (649)  
Net loss (5,946)         (5,946)
Ending balance at Oct. 31, 2021 43,861 $ 492 265,246 (227) (721) (220,929)
Ending balance, Shares at Oct. 31, 2021   49,212,173        
Beginning balance at Jul. 31, 2021 45,983 $ 492 264,972 (227) (430) (218,824)
Beginning balance, Shares at Jul. 31, 2021   49,212,173        
Stock-based compensation expense 274   274      
Foreign currency translation adjustments (291)       (291)  
Net loss (2,105)         (2,105)
Ending balance at Oct. 31, 2021 43,861 $ 492 265,246 (227) (721) (220,929)
Ending balance, Shares at Oct. 31, 2021   49,212,173        
Beginning balance at Jan. 31, 2022 42,524 $ 493 265,644 (227) (973) (222,413)
Beginning balance, Shares at Jan. 31, 2022   49,347,604        
Issuance of common stock pursuant to vesting of restricted stock units   $ 10 (10)      
Issuance of common stock pursuant to vesting of restricted stock units, shares   1,013,774        
Stock-based compensation expense 711   711      
Foreign currency translation adjustments (1,341)       (1,341)  
Short swing profit settlement 7   7      
Net loss (13,131)         (13,131)
Ending balance at Oct. 31, 2022 28,770 $ 503 266,352 (227) (2,314) (235,544)
Ending balance, Shares at Oct. 31, 2022   50,361,378        
Beginning balance at Jul. 31, 2022 32,567 $ 501 266,177 (227) (2,024) (231,860)
Beginning balance, Shares at Jul. 31, 2022   50,176,824        
Issuance of common stock pursuant to vesting of restricted stock units   $ 2 (2)      
Issuance of common stock pursuant to vesting of restricted stock units, shares   184,554        
Stock-based compensation expense 177   177      
Foreign currency translation adjustments (290)       (290)  
Net loss (3,684)         (3,684)
Ending balance at Oct. 31, 2022 $ 28,770 $ 503 $ 266,352 $ (227) $ (2,314) $ (235,544)
Ending balance, Shares at Oct. 31, 2022   50,361,378